Literature DB >> 17111125

Late recurrence of Wilms' tumour with exclusive skeletal muscle phenotype 23 years after primary diagnosis.

Rebecca Senetta1, Luigia Macrì, Donatella Pacchioni, Isabella Castellano, Paola Cassoni, Gianni Bussolati.   

Abstract

A late recurrence of Wilms' tumour (WT) 23 years after the primary diagnosis is described. The primary tumour occurred in a 10-month-old girl and showed various degrees of differentiation, including skeletal muscle phenotype. A postoperative chemotherapy was performed. Twenty-three years after the surgery, the tumour relapsed: the lesion was exclusively composed of mature skeletal muscle elements (diffuse and intense desmin reactivity) derived from the primary tumour as confirmed by WT1 immunoreactivity. Chemotherapy and radiotherapy have been reported previously to ablate the immature components of WT; especially, chemotherapy can modify the histological type, reducing the immature elements while leaving mature cells unaffected. We can hypothesise that both morphological and molecular features of the tumour as well as the effect of therapy can influence a tumour relapse in WT. The latter results in a high degree of differentiation and a long disease-free interval after the first diagnosis.

Entities:  

Mesh:

Year:  2006        PMID: 17111125     DOI: 10.1007/s00428-006-0326-y

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  18 in total

1.  The treatment of stages I-IV favorable histology Wilms' tumor.

Authors:  Daniel M Green
Journal:  J Clin Oncol       Date:  2004-04-15       Impact factor: 44.544

2.  Relapse of Wilms' tumor 13 years after original diagnosis.

Authors:  Paul J Gibson; Christina M Vadeboncoeur; Donna L Johnston
Journal:  J Pediatr Hematol Oncol       Date:  2005-05       Impact factor: 1.289

3.  Gain of 1q is associated with adverse outcome in favorable histology Wilms' tumors.

Authors:  S Hing; Y J Lu; B Summersgill; L King-Underwood; J Nicholson; P Grundy; R Grundy; M Gessler; J Shipley; K Pritchard-Jones
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

4.  Late local recurrence of Wilms' tumor.

Authors:  V Mikraki; G Yiannoulopoulos; M Moschovi; C Constantinidou-Van Vliet; F Tzortzatou-Stathopoulou
Journal:  Med Pediatr Oncol       Date:  1996-01

5.  Recurrence of Wilms tumor--twenty-three years later.

Authors:  J E Gottesman; E V Pellettiere; W Kilmer
Journal:  Urology       Date:  1981-03       Impact factor: 2.649

6.  A gene expression signature for relapse of primary wilms tumors.

Authors:  Wenliang Li; Patricia Kessler; Herman Yeger; Jennifer Alami; Anthony E Reeve; Rosemary Heathcott; Jane Skeen; Bryan R G Williams
Journal:  Cancer Res       Date:  2005-04-01       Impact factor: 12.701

7.  Recurrence of Wilms tumor after apparent cure.

Authors:  T H Kim; G S Zaatari; E S Baum; N Jaffe; B Cushing; R L Chard; G T Zwiren; J B Beckwith
Journal:  J Pediatr       Date:  1985-07       Impact factor: 4.406

8.  Improved survival for patients with recurrent Wilms tumor: the experience at St. Jude Children's Research Hospital.

Authors:  Jeffrey S Dome; Tiebin Liu; Matthew Krasin; Lennie Lott; Patricia Shearer; Najat C Daw; Catherine A Billups; Judith A Wilimas
Journal:  J Pediatr Hematol Oncol       Date:  2002 Mar-Apr       Impact factor: 1.289

9.  Late recurrent metastasis in Wilms' tumour.

Authors:  S Gallego-Melcón; J Sánchez de Toledo; D Doste; D López; F Moraga; C Rodríguez; T Vidal; J Bellmunt
Journal:  Med Pediatr Oncol       Date:  1994

10.  Prognostic classification of relapsing favorable histology Wilms tumor using cDNA microarray expression profiling and support vector machines.

Authors:  Richard D Williams; Sandra N Hing; Braden T Greer; Craig C Whiteford; Jun S Wei; Rachael Natrajan; Anna Kelsey; Simon Rogers; Colin Campbell; Kathy Pritchard-Jones; Javed Khan
Journal:  Genes Chromosomes Cancer       Date:  2004-09       Impact factor: 5.006

View more
  1 in total

1.  Wilms' Tumor with long-delayed recurrence: 25 years after initial treatment.

Authors:  So-Young Lee; Kyu-Rae Kim; Jung-Yeol Park; Jae Y Ro
Journal:  Korean J Urol       Date:  2012-04-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.